Evidence map›Paper›PMID 38388213›Full record

ReviewTrends in cancer2024

Tumor-resident microbes: the new kids on the microenvironment block.

Le Li, Vidhi Chandra, Florencia McAllister

Open access · hybridAbstract readReview
In one paragraph

Review in Trends in cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Programming the tumor microenvironment through microbiome-driven mechanisms.Frontiers in cellular and infection microbiology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. A deadly taste: linking bitter taste receptors and apoptosis.Apoptosis : an international journal on programmed cell death · 2025
    Review
  11. Article
  12. Review
  13. Host-microbe-cancer interactions on-a-chip.Frontiers in bioengineering and biotechnology · 2025
    Review
  14. Review
  15. Microbial signatures in metastatic cancer.Frontiers in medicine · 2025
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Le LiDepartment of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vidhi ChandraDepartment of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Florencia McAllisterDepartment of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: fmcallister@mdanderson.org.
The University of Texas MD Anderson Cancer Center · US

Funding

Dissecting the Source and Mechanisms of IL-17-Mediated Modulation of Pancreatic TumorigenesisR37CA237384 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MCALLISTER, FLORENCIA · 2020 to 2025
$2.6M
NCI NIH HHS R37 CA237384
6 · The paper itself

Abstract

Tumor-resident microbes (TRM) are an integral component of the tumor microenvironment (TME). TRM can influence tumor growth, distant dissemination, and response to therapies by interfering with molecular pathways in tumor cells as well as with other components of the TME. Novel technologies are improving the identification and visualization of cell type-specific microbes in the TME. The mechanisms that mediate the role of TRM at the primary tumors and metastatic sites are being elucidated. This knowledge is providing novel perspectives for targeting microbes or using microbial interventions for cancer interception or therapy.

Indexed as

NeoplasmsHumansImmunotherapyTumor Microenvironmentcancerimmunitymetastasismicroenvironmenttumorigenesistumor-resident microbes

Identifiers

PMID38388213
PMCPMC11006566
OpenAlexW4392055196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.